Liquid biopsies, are we ready for prime time?

被引：3

作者：

Normanno, Nicola ^{[1
]}

Apostolidis, Kathi ^{[2
]}

Stewart, Mark ^{[3
]}

机构：

[1] Ist Nazl Tumori IRCCS Fdn Pascale, Cell Biol & Biotherapy Unit, Naples, Italy

[2] European Canc Patient Coalit, Brussels, Belgium

[3] Friends Canc Res, Washington, DC USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2023年 / 11卷 / 02期

关键词：

Biomarkers; Tumor; ERLOTINIB; PREDICTOR; MUTATION; DNA;

D O I：

10.1136/jitc-2022-006302

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 16 条

[1] Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers' survey [J].

Deans, Zandra C. ;

Williams, Hannah ;

Dequeker, Elisabeth M. C. ;

Keppens, Cleo ;

Normanno, Nicola ;

Schuuring, Ed ;

Patton, Simon J. ;

Cheetham, Melanie ;

Butler, Rachel ;

Hall, Jacqueline A. .

VIRCHOWS ARCHIV, 2017, 471 (06) :809-813

[2] Results of a worldwide external quality assessment of cfDNA testing in lung Cancer [J].

Fairley, Jennifer A. ;

Cheetham, Melanie H. ;

Patton, Simon J. ;

Rouleau, Etienne ;

Denis, Marc ;

Dequeker, Elisabeth M. C. ;

Schuuring, Ed ;

van Casteren, Kaat ;

Fenizia, Francesca ;

Normanno, Nicola ;

Deans, Zandra C. .

BMC CANCER, 2022, 22 (01)

[3] Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study [J].

Fukuhara, Tatsuro ;

Saito, Haruhiro ;

Furuya, Naoki ;

Watanabe, Kana ;

Sugawara, Shunichi ;

Iwasawa, Shunichiro ;

Tsunezuka, Yoshio ;

Yamaguchi, Ou ;

Okada, Morihito ;

Yoshimori, Kozo ;

Nakachi, Ichiro ;

Gemma, Akihiko ;

Azuma, Koichi ;

Kurimoto, Futoshi ;

Tsubata, Yukari ;

Fujita, Yuka ;

Nagashima, Hiromi ;

Asai, Gyo ;

Watanabe, Satoshi ;

Miyazaki, Masaki ;

Hagiwara, Koichi ;

Nukiwa, Toshihiro ;

Morita, Satoshi ;

Kobayashi, Kunihiko ;

Maemondo, Makoto .

EBIOMEDICINE, 2020, 57

[4] Evaluation of cell-free DNA approaches for multi-cancer early detection [J].

Jamshidi, Arash ;

Liu, Minetta C. ;

Klein, Eric A. ;

Venin, Oliver ;

Hubbell, Earl ;

Beausang, John F. ;

Gross, Samuel ;

Melton, Collin ;

Fields, Alexander P. ;

Liu, Qinwen ;

Zhang, Nan ;

Fung, Eric T. ;

Kurtzman, Kathryn N. ;

Amini, Hamed ;

Betts, Craig ;

Civello, Daniel ;

Freese, Peter ;

Calef, Robert ;

Davydov, Konstantin ;

Fayzullina, Saniya ;

Hou, Chenlu ;

Jiang, Roger ;

Jung, Byoungsok ;

Tang, Susan ;

Demas, Vasiliki ;

Newman, Joshua ;

Sakarya, Onur ;

Scott, Eric ;

Shenoy, Archana ;

Shojaee, Seyedmehdi ;

Steffen, Kristan K. ;

Nicula, Virgil ;

Chien, Tom C. ;

Bagaria, Siddhartha ;

Hunkapiller, Nathan ;

Desai, Mohini ;

Dong, Zhao ;

Richards, Donald A. ;

Yeatman, Timothy J. ;

Cohn, Allen L. ;

Thiel, David D. ;

Berry, Donald A. ;

Tummala, Mohan K. ;

MCIntyre, Kristi ;

Sekeres, Mikkael A. ;

Bryce, Alan ;

Aravanis, Alexander M. ;

V. Seiden, Michael ;

Swanton, Charles .

CANCER CELL, 2022, 40 (12) :1537-+

[5] Precision Combination Therapies Based on Recurrent Oncogenic Coalterations [J].

Li, Xubin ;

Dowling, Elisabeth K. ;

Yan, Gonghong ;

Dereli, Zeynep ;

Bozorgui, Behnaz ;

Imanirad, Parisa ;

Elnaggar, Jacob H. ;

Luna, Augustin ;

Menter, David G. ;

Pilie, Patrick G. ;

Yap, Timothy A. ;

Kopetz, Scott ;

Sander, Chris ;

Korkut, Anil .

CANCER DISCOVERY, 2022, 12 (06) :1542-1559

[6] Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease [J].

Moding, Everett J. ;

Nabet, Barzin Y. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

CANCER DISCOVERY, 2021, 11 (12) :2968-2986

[7] Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy [J].

Mok, Tony ;

Wu, Yi-Long ;

Lee, Jin Soo ;

Yu, Chong-Jen ;

Sriuranpong, Virote ;

Sandoval-Tan, Jennifer ;

Ladrera, Guia ;

Thongprasert, Sumitra ;

Srimuninnimit, Vichien ;

Liao, Meilin ;

Zhu, Yunzhong ;

Zhou, Caicun ;

Fuerte, Fatima ;

Margono, Benjamin ;

Wen, Wei ;

Tsai, Julie ;

Truman, Matt ;

Klughammer, Barbara ;

Shames, David S. ;

Wu, Lin .

CLINICAL CANCER RESEARCH, 2015, 21 (14) :3196-3203

[8] Access and quality of biomarker testing for precision oncology in Europe [J].

Normanno, Nicola ;

Apostolidis, Kathi ;

Wolf, Audrey ;

Al Dieri, Raed ;

Deans, Zandra ;

Fairley, Jenni ;

Maas, Jorg ;

Martinez, Antonio ;

Moch, Holger ;

Pilz, Thomas ;

Nielsen, Soren ;

Rouleau, Etienne ;

Patton, Simon ;

Williams, Victoria .

EUROPEAN JOURNAL OF CANCER, 2022, 176 :70-77

[9] Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems [J].

Normanno, Nicola ;

Apostolidis, Kathi ;

de Lorenzo, Francesco ;

Beer, Philip A. ;

Henderson, Raymond ;

Sullivan, Richard ;

Biankin, Andrew V. ;

Horgan, Denis ;

Lawler, Mark .

SEMINARS IN CANCER BIOLOGY, 2022, 84 :293-301

[10] Targeting the EGFR T790M mutation in non-small-cell lung cancer [J].

Normanno, Nicola ;

Maiello, Monica Rosaria ;

Chicchinelli, Nicoletta ;

Iannaccone, Alessia ;

Esposito, Claudia ;

De Cecio, Rossella ;

D'alessio, Amelia ;

De Luca, Antonella .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) :159-165

← 1 2 →